Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 4,319 | 4,427 | 4,166 | 4,004 | 4,079 |
| Cost of Goods | 2,650 | N/A | N/A | 2,530 | N/A |
| Gross Profit | 1,660 | 4,427 | 4,166 | 1,490 | 4,079 |
| Operating Expenses | 2,290 | 0 | 0 | 2,270 | 0 |
| Operating Income | 29 | 4,427 | 4,166 | -266 | 4,079 |
| Interest Expense | 0 | 0 | 0 | 220 | 0 |
| Other Income | -9 | 0 | 0 | 1,346 | 0 |
| Pre-tax Income | 20 | 4,427 | 4,166 | 860 | 4,079 |
| Net Income Continuous | 20 | -296 | 287 | 920 | -481 |
| Net Income | $20 | $-296 | $287 | $920 | $-481 |
| EPS Basic Total Ops | 0.00 | -0.04 | 0.04 | 0.12 | -0.06 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | 0.04 | 0.12 | -0.06 |
| EPS Diluted Total Ops | 0.00 | -0.04 | 0.04 | 0.12 | -0.06 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | 0.04 | 0.12 | -0.06 |
| EBITDA(a) | $29 | $4,427 | $4,166 | $-266 | $4,079 |